tiprankstipranks
Trending News
More News >

Extrawell Pharmaceutical Schedules Board Meeting for Annual Results Approval

Story Highlights
Extrawell Pharmaceutical Schedules Board Meeting for Annual Results Approval

Don’t Miss TipRanks’ Half-Year Sale

An announcement from Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) is now available.

Extrawell Pharmaceutical Holdings Limited has announced a board meeting scheduled for June 30, 2025, to approve the annual results for the fiscal year ending March 31, 2025. This meeting is crucial as it will determine the company’s financial performance and strategic direction, impacting stakeholders and potentially influencing its market positioning.

More about Extrawell Pharmaceutical Holdings Limited

Extrawell Pharmaceutical Holdings Limited is a company in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company operates with a market focus on healthcare solutions and related services.

Average Trading Volume: 621,636

Technical Sentiment Signal: Buy

Current Market Cap: HK$124.3M

For detailed information about 0858 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1